Veracyte is a startup based in the United States, 1 tracked investor.
Based in the United States, Veracyte is a startup founded in 2014. Brouky records 1 investor associated with the company.
Veracyte develops molecular diagnostic tests that analyze the biology of tumors to assist clinicians in making personalized treatment decisions for various cancers including thyroid, prostate, breast, bladder, and lung cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.